Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Endo Health Solutions Inc    EPV   US29264F2056

End-of-day quote. End-of-day quote Deutsche Boerse AG - 05/22
26.127 EUR   +0.04%
05/13DJU.S. HOT STOCKS FUTURES: Hot stocks to watch
05/13DJU.S. HOT STOCKS FUTURES: Hot stocks to watch
05/10 ENDO HEALTH SOLUTIONS INC: Endo Health Solutions Responds to FDA's Denial ..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Endo Health Solutions Inc : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales1 7162 7303 0272 8002 4672 410
Operating income (EBITDA)6751 0061 149909801777
Operating profit (EBIT)6519601 079887757743
Pre-Tax Profit (EBT)---742---
Net income259188-740178246213
EPS ( $)2,201,55-6,401,802,232,04
Dividend per Share ( $)------
Yield------
Announcement Date02/28/2011
12:30pm		02/24/2012
12:00pm		02/28/2013
09:07pm		---
Finances - Leverage
Endo Health Solutions Inc : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt6052 8772 6242 4942 3221 932
Finance------
Operating income (EBITDA)6751 0061 149909801777
Leverage
(Debt/EBITDA)		0,90x2,86x2,28x2,74x2,90x2,49x
Capital Expenditure19,959,499,8120116114
Book Value Per Share (BVPS)15,0 $16,9 $9,68 $9,30 $11,2 $13,5 $
Cash Flow per Share3,85 $5,79 $6,06 $2,16 $1,90 $-
Announcement Date02/28/2011
12:30pm		02/24/2012
12:00pm		02/28/2013
09:07pm		---
Balance Sheet Analysis
Endo Health Solutions Inc : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 3 774 M$ -
Company Value 6 268 M$ 6 095 M$
Valuation 2013e 2014e
PER (Price / EPS) 18,6x 15,1x
Capitalization / Revenue 1,35x 1,53x
EV / Revenue 2,24x 2,47x
EV / EBITDA 6,89x 7,61x
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 31,7% 30,7%
operating laverage (Delta EBIT / Delta Sales) -2,37x -1,23x
Net Margin (Net Profit / Revenue) 6,34% 9,96%
ROA (Net Profit / Asset) 6,30% 6,60%
ROE (Net Profit / Equities) 36,9% 34,1%
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   4,27% 4,69%
Cash Flow / Sales (Taux d'autofinancement) 8,67% 8,66%
Capital Intensity (Assets / Sales) 1,01x 1,51x
Financial Leverage (Net Debt / EBITDA) 2,74x 2,90x
Price Earning Ratio
Endo Health Solutions Inc : Price Earning Ratio
EPS & Dividend
Endo Health Solutions Inc : EPS Dividend
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.